Latest filing published 27 Mar 2023 for Akoya Biosciences, Inc., €1,257.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Garry Nolan PhD: trading record in brief
Garry Nolan PhD is a declared insider of Akoya Biosciences, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 12 filings, for trades running from 9 December 2021 to 13 December 2022.
Every open-market trade on record is a sale: 12 sales worth €1.1M. So far in 2023, the count stands at no purchases and 1 sale.
The latest filing, published on 27 March 2023, reports an open-market sale of €1,257 in Akoya Biosciences, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Garry Nolan PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$13.250.1% of flowCommon StockSEC:0001104659-23-037255:0
- 100 shares@ US$13.250.1% of flowCommon StockSEC:0001104659-22-127461:0
- 1,100 shares@ US$13.251.2% of flowCommon StockSEC:0001104659-22-124983:0
- 5,000 shares@ US$13.35765.7% of flowCommon StockSEC:0001104659-22-124078:0
- 300 shares@ US$13.25330.3% of flowCommon StockSEC:0001104659-22-119969:0
- 3,810 shares@ US$13.30854.5% of flowCommon StockSEC:0001104659-22-118809:0
- 8,305 shares@ US$13.25529.8% of flowCommon StockSEC:0001104659-22-100936:0
- 22,191 shares@ US$13.308926.3% of flowCommon StockSEC:0001104659-22-099627:0
- 1,800 shares@ US$13.30232.1% of flowCommon StockSEC:0001104659-22-099627:1
- 25,000 shares@ US$12.670533.2% of flowCommon StockSEC:0001104659-21-149196:0
10 of 10 declarations